Aligos Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US01626L1052
USD
5.51
0.77 (16.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAligos Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
16.24%
-0.18%
1W
27.55%
3.66%
1M
-5.81%
2.29%
YTD
-40.88%
12.63%
1Y
-31.47%
21.51%
3Y
522.6%
72.17%
5Y
-98.61%
73.78%
10Y
%
253.2%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.5%
0%
-13.5%
6 Months
-24.73%
0%
-24.73%
1 Year
-31.47%
0%
-31.47%
2 Years
-50.69%
0%
-50.69%
3 Years
522.6%
0%
522.6%
4 Years
-85.31%
0%
-85.31%
5 Years
-98.61%
0%
-98.61%

Aligos Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary